Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology firm, will ring the Nasdaq opening bell at MarketSite in Times Square, New York on Wednesday, August 28, 2024. “Today, we…
VION Biosciences, a life science platform company specializing in specialty reagents for research, diagnostics, and drug discovery, has announced the acquisition of Echelon Biosciences, a Salt Lake City-based supplier known…
EMulate Therapeutics, Inc. has announced that the Open Journal of Biophysics (OJBIPHY) will publish its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating…
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs…
Commonwealth Care Alliance (CCA) has expanded its provider agreement with Beth Israel Lahey Health (BILH) to enhance care access for its Senior Care Options (SCO) and One Care members. This…
Concentra®, a leading provider of occupational medicine, has announced the introduction of its new behavioral health service on Concentra Telemed®, the company’s telemedicine platform for workers’ compensation. Concentra® has introduced…
Pulse Biosciences, Inc. (Nasdaq: PLSE) has announced the appointment of Paul A. LaViolette to its Board of Directors. Mr. LaViolette will serve as Co-Chairman alongside Robert W. Duggan, bringing his…
Masimo (NASDAQ: MASI) has announced that the Masimo W1® medical watch has received FDA 510(k) clearance for integration with the Masimo SafetyNet® telemonitoring system. The Masimo W1®—the first medical watch…
PhotoPharmics, a leader in phototherapy for neurodegenerative diseases, has announced the enrollment of the first 100 participants in its Light for PD clinical trial. This milestone is a key step…
LEAP Consulting Group, a specialized digital consultancy for the clinical laboratory sector, is thrilled to introduce a new service designed to assist CLIA-certified labs in navigating the FDA’s updated requirements…
Advanced Sterilization Products (ASP), a division of Fortive (NYSE: FTV), and PENTAX Medical, a division of HOYA, are excited to announce FDA clearance for the new ULTRA GI™ Cycle. This…